Please, pharma companies loath vaccines. Vaccines are expensive to develop and difficult to sell for large amounts of money. While the initiation of a vaccination program requires a large amount of vaccine to be produced, afterwards it only requires minimal upkeep, which makes return on investment hard.
No, you want to make money in as a pharmacological company? Don't sell a vaccine, don't sell a cure either. Customers who buy vaccines and cures don't come back. Sell a treatment that has to be maintained until the day the customer dies, and you'll have a loyal customer who keeps paying.
No, you want to make money in as a pharmacological company? Don't sell a vaccine, don't sell a cure either. Customers who buy vaccines and cures don't come back. Sell a treatment that has to be maintained until the day the customer dies, and you'll have a loyal customer who keeps paying.